News
13h
Investor's Business Daily on MSNIBD 50 Stock Flashes 'Golden Cross' But Massive Risk LoomsAni Pharmaceuticals stock is near a buy point in a cup with handle base after flashing a "golden cross" signal.
New drug delivery technologies, such as nanoparticles, hydrogels, and self-powered microgrippers, are showing great potential ...
15h
Investor's Business Daily on MSNIBD Rating Upgrades: Sun Communities Flashes Improved Technical StrengthSun Communities holds the No. 81 rank among its peers in the Finance-Property REITs industry group. CareTrust REIT, Omega ...
Ella Rhian had never experienced any stomach problems before and lived a normal, healthy life. Then, in September 2023, the ...
Patients with LVV and IBD present with distinct clinical characteristics, including earlier onset and more severe vascular involvement.
9d
News-Medical.Net on MSNStudy reveals disparities in healthcare utilization among racial and ethnic groups with IBDA study published today in the American Journal of Gastroenterology reveals significant disparities in healthcare utilization ...
Inflammatory bowel disease (IBD) is associated with increased risks for genitourinary cancers, including prostate cancer and renal cell carcinoma (RCC), according to study results presented at the ...
Take Steps is the Crohn’s & Colitis Foundation’s signature fundraising event. This year (2025), the event will take place at ...
Explore the promising results of haematopoietic stem cell transplantation as a treatment for early-onset inflammatory bowel ...
People with inflammatory bowel disease (IBD) also report more panic and anxiety. The threat of flare-ups can keep people worried and on guard and make gut symptoms worse.
3d
India Today on MSNIs your vitamin D low? Your gut might be paying the priceThat post-lunch bloat, those unpredictable bathroom visits, and even chronic conditions like IBS or IBD could be tied to that sunshine vitamin you’ve been neglecting.
Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results